# EDGAR Filing Document

**Accession Number:** 0001472827
**File Stem:** 0001472827-23-000005
**Filing Date:** 2023-3
**Character Count:** 7653
**Document Hash:** 02c9acde476af3fc3d254dcd3abc4360
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001472827-23-000005.hdr.sgml**: 20230302

**ACCESSION NUMBER**: 0001472827-23-000005

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230301

**FILED AS OF DATE**: 20230302

**DATE AS OF CHANGE**: 20230302

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Solaiman Shereen
- **CENTRAL INDEX KEY:** 0001472827

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26642
- **FILM NUMBER:** 23699000

**MAIL ADDRESS:**
- **STREET 1:** 320 WAKARA WAY
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84108
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MYRIAD GENETICS INC
- **CENTRAL INDEX KEY:** 0000899923
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 870494517
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 320 WAKARA WAY
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84108
- **BUSINESS PHONE:** 801-584-3600

**MAIL ADDRESS:**
- **STREET 1:** 320 WAKARA WAY
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84108

## Ex-24

```

POWER OF ATTORNEY

Know all by these presents, that the undersigned
hereby constitutes and appoints each of
R. Bryan Riggsbee, Pamela Wong, Natalie Munk,
and Justin Hunter of Myriad Genetics, Inc.
(the "Company"), signing singly, with
full power of substitution, the undersigned's true
and lawful attorney-in-fact to:

(1)     execute for and on behalf of
the undersigned, in the undersigned's
capacity as an officer, director and/or
10% shareholder of the Company, Forms 3, 4
and 5 (and any amendments thereto) in
accordance with Section 16(a) of the Securities
Exchange Act of 1934, as amended
(the "Exchange Act"), and the rules thereunder;

(2)    do and perform any and all acts for
and on behalf of the undersigned which may be
necessary or desirable to complete and execute
any such Form 3,4 or 5, complete and execute any
amendments thereto,and timely file such form
with the United States Securities and
Exchange Commission (the SEC) and any stock
exchange or similar authority, including without
limitation the filing of a Form ID or any other documents
necessary or appropriate to enable the
undersigned to file the Forms 3, 4 and 5
electronically with the SEC;

(3)    seek or obtain, as the undersigned's representative
and on the undersigned's behalf, information on
transactions in the Company's securities from any third party,
including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes
any such person to release any such information
to each of the undersigned's attorneys-in-fact appointed
by this Power of Attorney and approves and ratifies any
such release of information; and

(4)    take any other action of any type whatsoever
in connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by,
the undersigned, it being understood that the documents
executed by such attorney-in-fact, on behalf of the
undersigned pursuant to this Power of Attorney,
shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such
attorney-in-fact full power and authority to
do and perform any and every act and
thing whatsoever requisite, necessary,or
proper to be done in the exercise of any of
the rights and powers herein  granted,
as fully to all intents and purposes as the
undersigned might or could do if personally present,
with full power of substitution or revocation,
hereby ratifying and confirming all that
such attorney-in-fact, or such attorney-in-fact's
substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and
the rights and powers herein granted. The
undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity
at the request of the undersigned, is not assuming,
nor is the Company assuming, any of the
undersigned's responsibilities to comply with
Section 16 of the Exchange Act.

This Power of Attorney shall remain in
full force and effect until the undersigned
is no longer required to file Forms 3, 4
and 5 with respect to the undersigned's
holdings of and transactions in securities
issued by the Company, unless earlier revoked
by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned
has caused this Power of Attorney to
be executed this 17th day of February, 2023.

/S/ Shereen Solaiman

Shereen Solaiman

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Solaiman Shereen<br><sub>(Last) (First) (Middle)</sub><br>320 WAKARA WAY<br><sub>(Street)</sub><br>SALT LAKE CITY, UT 84108<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>MYRIAD GENETICS INC [ MYGN ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-03-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief People Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit List: Exhibit 24 - Power of Attorney

**Signature:** By: Justin Hunter For: Shereen Solaiman  
**Date:** 2023-03-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**